Mayo Clinic: Carcinoma, Hepatocellular trials

The registry lists 16 Carcinoma, Hepatocellular studies with Mayo Clinic as lead sponsor. 6 are open to participants now and 3 have results posted.

Early Phase 1 2Phase 1 3Phase 2 8No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
• Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver CancerRecruitingNCT03942328Phase 1/2
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• 68Ga PSMA PET Imaging for the Treatment of Advanced Liver CancerCompletedNCT05176223Phase 2Results posted
• Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver CancerCompletedNCT04828486Phase 2Results posted
• 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver CancerCompletedNCT04762888Phase 2Results posted
• Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular CarcinomaWithdrawnNCT05111314Early Phase 1
• Stereotactic Body Proton Radiotherapy for the Treatment of Liver CancerTerminatedNCT04805788Phase 2
• PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver CancerCompletedNCT04310540Early Phase 1
• Liver and Biliary Tumor Tissue RegistryTerminatedNCT02917759
• Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
• Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian ImmigrantsCompletedNCT02366286
• Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid TumorsCompletedNCT01628640Phase 1